Company / Net Debt per Share
Bionano Genomics, Inc. Net Debt per Share History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.13
FY2021
5-year range
-$0.13 / -$0.13
FY2018-FY2021
Trend
+80.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.28 to $-0.13 over the past 2 years.
Based on SEC 10-K filings.
-0.13 in FY2021.
Improved from $0.28 to $-0.13 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, net debt per share increased 80.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$0.13 | +80.0% |
| FY2020 | -$0.65 | -334.0% |
| FY2019 | $0.28 | +100.3% |
| FY2018 | -$96.99 | - |
As of FY2021 · SEC Form 10-K · Last checked Jun 22, 2026